High‐definition transcranial direct current stimulation over right dorsolateral prefrontal cortex differentially modulates inhibitory mechanisms for speech vs. limb movement
Psychophysiology · 2023
DOI: 10.1111/psyp.14289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychophysiology, 2023. Verfasst von Karim Johari und 1 weiteren Autor:innen. Beteiligte Einrichtung: Human Neurophysiology and Neuromodulation Laboratory, Department of Communication Sciences and Disorders, Louisiana State University, Baton Rouge, Lo…. Hauptthemen laut MEDLINE: Transcranial Direct Current Stimulation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: Medical Research Council, College of Humanities and Social Sciences, Louisiana State University, Louisiana Board of Regents.
Abstract (Originalsprache)
Evidence suggests that planning and execution of speech and limb movement are subserved by common neural substrates. However, less is known about whether they are supported by a common inhibitory mechanism. P3 event‐related potentials (ERPs) is a neural signature of motor inhibition, which are found to be generated by several brain regions including the right dorsolateral prefrontal cortex (rDLPFC). However, the relative contribution of rDLPFC to the P3 response associated with speech versus limb inhibition remains elusive. We investigated the contribution of rDLPFC to the P3 underlying speech versus limb movement inhibition. Twenty‐one neurotypical adults received both cathodal and sham high‐definition transcranial direct current stimulation (HD‐tDCS) over rDLPFC. ERPs were subsequently recorded while subjects were performing speech and limb Go/No‐Go tasks. Cathodal HD‐tDCS decreased accuracy for speech versus limb No‐Go. Both speech and limb No‐Go elicited a similar topographical distribution of P3, with significantly larger amplitudes for speech versus limb at a frontocentral location following cathodal HD‐tDCS. Moreover, results showed stronger activation in cingulate cortex and rDLPFC for speech versus limb No‐Go following cathodal HD‐tDCS. These results indicate (1) P3 is an ERP marker of amodal inhibitory mechanisms that support both speech and limb inhibition, (2) larger P3 for speech versus limb No‐Go following cathodal HD‐tDCS may reflect the recruitment of additional neural resources—particularly within rDLPFC and cingulate cortex—as compensatory mechanisms to counteract the temporary stimulation‐induced decline in speech inhibitory process. These findings have translational implications for neurological conditions that concurrently affect speech and limb movement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Human Neurophysiology and Neuromodulation Laboratory, Department of Communication Sciences and Disorders, Louisiana State University, Baton Rouge, Louisiana, USA.
- Human Brain Research Laboratory, Department of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
ORCID-Profile: Karim Johari
Förderung
- Medical Research Council
- College of Humanities and Social Sciences, Louisiana State University
- Louisiana Board of Regents
- Medical Research Council Canada
Zitieren
APA
Johari, K., & Berger, J. I. (2023). High‐definition transcranial direct current stimulation over right dorsolateral prefrontal cortex differentially modulates inhibitory mechanisms for speech vs. limb movement. Psychophysiology. https://doi.org/10.1111/psyp.14289
Vancouver
Johari K, Berger JI. High‐definition transcranial direct current stimulation over right dorsolateral prefrontal cortex differentially modulates inhibitory mechanisms for speech vs. limb movement. Psychophysiology. 2023. doi:10.1111/psyp.14289
BibTeX
@article{Johari2023,
author = {Johari, Karim and Berger, Joel I},
title = {High‐definition transcranial direct current stimulation over right dorsolateral prefrontal cortex differentially modulates inhibitory mechanisms for speech vs. limb movement},
journal = {Psychophysiology},
year = {2023},
doi = {10.1111/psyp.14289}
}
EUVIMED